Active Ingredient: BUDESONIDE
Proprietary Name: BUDESONIDE
Dosage Form; Route of Administration: CAPSULE, DELAYED RELEASE; ORAL
Strength: 3MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A206724
Product Number: 001
Approval Date: Nov 23, 2016
Applicant Holder Full Name: NATCO PHARMA LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information